AstraZeneca: Forskelle mellem versioner
Content deleted Content added
Pugilist (diskussion | bidrag) Fjerner version 9280931 af Pugilist (diskussion) - tyk tommel |
Pugilist (diskussion | bidrag) billede + diagram over historie |
||
Linje 64:
'''AstraZeneca''' er én af verdens største [[medicinalvirksomhed]]er. Virksomheden er dannet ved en fusion af svenske Astra og engelske Zeneca og omsatte i [[2006]] for ca. 145 mia. [[Danske kroner|DKK]].
Virksomheden har ca. 67.000 ansatte i følgende lande: [[Sverige]] 21%, [[USA]] 20%, [[Storbritannien]] 18% og resten af verden 41%.
==Opkøb og fusioner==
[[File:Astra headquarters Södertälje.JPG|thumb|Astras hovedkvarter i [[Södertälje]].]]
Nedenfor en illustration af selskabets væsentligste opkøb og fusioner og historiske rødder:<ref>{{cite web|url=http://www.astrazeneca-annualreports.com/2014/assets/pdf/Principal_Subsidiaries.pdf|title=A comprehensive list of AstraZeneca's subsidiary holdings|publisher=AstraZeneca}}</ref>
{{clade | style=font-size:90%;line-height:110% |thickness=0
|label1=<span style="font-size:100%;">AstraZeneca</span><!-- LEVEL 1-->
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=
|1={{clade
|label1=[[Astra AB]]<br/><small>(Merged 1999)</small>
|1={{clade
|label1=
|1=Astra<br/><small>(Founded 1913)</small>
|2=Tika<br/><small>(Acq 1939)</small>
}}
|label2=[[Zeneca]]<br/><small>(Merged 1999)</small>
|2= {{clade
|2=Ishihara Sangyo Kaisha<br/><small>(US fungicide operations, Acq 1997)</small>
|1={{clade
|1=Zeneca<br/><small>(Spun off from Imperial Chemical Industries 1993)</small>
|2=Salick Health Care<br/><small>(Acq 1996)</small>
}}
}}
}}
}}
}}
|label2=
|2= {{clade
|1= KuDOS Pharmaceuticals<br/><small>(Acq 2005)</small>
}}
}}
|label2=
|2= {{clade
|1= [[Cambridge Antibody Technology]]<br/><small>(Acq 2006)</small>
|2= Aptein Inc<br/><small>(Acq 1998)</small>
}}
}}
|label2=
|2= {{clade
|1= Arrow Therapeutics<br/><small>(Acq 2007)</small>
}}
}}
|label2=
|2= {{clade
|1= [[MedImmune]]<br/><small>(Acq 2007)</small>
|2= [[Definiens]]<ref>{{cite web|url=http://www.astrazeneca.com/Media/Press-releases/Article/20141126--medimmune-completes-acquisition-of-definiens|title=AstraZeneca - MedImmune completes acquisition of Definiens|work=astrazeneca.com}}</ref><br/><small>(Acq 2014)</small>
}}
}}
|label2=
|2= {{clade
|1= Novexel Corp<br/><small>(Acq 2010)</small>
}}
}}
|label2=
|2= {{clade
|1= Guangdong BeiKang Pharmaceutical Company<br/><small>(Acq 2011)</small>
}}
}}
|label2=
|2= {{clade
|1= Ardea Biosciences<br/><small>(Acq 2012)</small>
}}
}}
|label2=
|2= {{clade
|1=[[Amylin Pharmaceuticals]]<br/><small>(Acq 2012 jointly with [[Bristol-Myers Squibb ]])</small>
}}
}}
|label2=
|2= {{clade
|1=Spirogen<br/><small>(Acq 2013)</small>
}}
}}
|label2=
|2= {{clade
|1=Pearl Therapeutics<ref>{{cite web|url=http://www.astrazeneca.com/Media/Press-releases/Article/20130610--az-acquire-pearl|title=AstraZeneca - AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio|work=astrazeneca.com}}</ref><br/><small>(Acq 2013)</small>
}}
}}
|label2=
|2= {{clade
|1=Omthera Pharmaceuticals<ref>{{cite web|url=http://www.astrazeneca.com/Media/Press-releases/Article/20130528-omthera|title=AstraZeneca - AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio|work=astrazeneca.com}}</ref><br/><small>(Acq 2013)</small>
}}
}}
|label2=
|2= {{clade
|1=Bought out [[Bristol-Myers Squibb]]'s share of joint diabetes assets, 2013<ref>{{cite web|url=http://www.astrazeneca.com/Media/Press-releases/Article/20121218--AstraZeneca-acquire-Bristol-Myers-Squibb-share-global-diabetes-alliance-assets|title=AstraZeneca - AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets|work=astrazeneca.com}}</ref>
}}
}}
|label2=
|2= {{clade
|1=Entasis Therapeutics<ref>{{cite web|url=http://www.fiercebiotech.com/story/whittled-down-biotech-size-astrazenecas-antibiotics-crew-starts-over-entasi/2015-07-01|title=Whittled down to biotech size, AstraZeneca's antibiotics crew starts over as Entasis|work=FierceBiotech}}</ref><br/><small>(Spun off 2015)</small>
}}
}}
|label2=
|2= {{clade
|1=ZS Pharma<br/><small>(Acq 2015)</small>
}}
}}
}}
== Referencer ==
{{reflist}}
== Eksterne henvisninger ==
| |||